Literature DB >> 23001710

Rapid decline in episodic memory in healthy older adults with high amyloid-β.

Yen Ying Lim1, Robert H Pietrzak, Kathryn A Ellis, Judith Jaeger, Karra Harrington, Tim Ashwood, Cassandra Szoeke, Ralph N Martins, Ashley I Bush, Colin L Masters, Christopher C Rowe, Victor L Villemagne, David Ames, David Darby, Paul Maruff.   

Abstract

High levels of amyloid-β (Aβ) have been associated with greater rates of decline in episodic memory over 18 months in healthy older adults. Serial assessments over shorter time intervals may facilitate earlier detection of Aβ-related memory decline in healthy older adults. In forty-four healthy older adults enrolled in the Australian Imaging, Biomarkers and Lifestyle Rate of Change Sub-Study, we compared rates of change in cognition over six months in healthy older adults with high and low levels of Aβ. High Aβ was associated with greater decline in episodic memory measures over 6 months in healthy older adults.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23001710     DOI: 10.3233/JAD-2012-121516

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  29 in total

1.  Alzheimer Disease Cerebrospinal Fluid Biomarkers Moderate Baseline Differences and Predict Longitudinal Change in Attentional Control and Episodic Memory Composites in the Adult Children Study.

Authors:  Andrew J Aschenbrenner; David A Balota; Anne M Fagan; Janet M Duchek; Tammie L S Benzinger; John C Morris
Journal:  J Int Neuropsychol Soc       Date:  2015-09       Impact factor: 2.892

2.  Posttraumatic stress disorder symptoms and cognitive function in a large cohort of middle-aged women.

Authors:  Jennifer A Sumner; Kaitlin Hagan; Fran Grodstein; Andrea L Roberts; Brian Harel; Karestan C Koenen
Journal:  Depress Anxiety       Date:  2017-01-10       Impact factor: 6.505

3.  Amyloid deposition is linked to aberrant entorhinal activity among cognitively normal older adults.

Authors:  Willem Huijbers; Elizabeth C Mormino; Sarah E Wigman; Andrew M Ward; Patrizia Vannini; Donald G McLaren; J Alex Becker; Aaron P Schultz; Trey Hedden; Keith A Johnson; Reisa A Sperling
Journal:  J Neurosci       Date:  2014-04-09       Impact factor: 6.167

4.  Alzheimer-Like Pattern of Hypometabolism Emerges with Elevated Amyloid-β Burden in Down Syndrome.

Authors:  Patrick J Lao; Ben L Handen; Tobey J Betthauser; Iulia Mihaila; Sigan L Hartley; Annie D Cohen; Dana L Tudorascu; Peter D Bulova; Brian J Lopresti; Rameshwari V Tumuluru; Dhanabalan Murali; Chester A Mathis; Todd E Barnhart; Charles K Stone; Julie C Price; Darlynne A Devenny; Sterling C Johnson; William E Klunk; Bradley T Christian
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

5.  Diffusion Tensor Imaging Predictors of Episodic Memory Decline in Healthy Elders at Genetic Risk for Alzheimer's Disease.

Authors:  Melissa A Lancaster; Michael Seidenberg; J Carson Smith; Kristy A Nielson; John L Woodard; Sally Durgerian; Stephen M Rao
Journal:  J Int Neuropsychol Soc       Date:  2016-11       Impact factor: 2.892

Review 6.  The evolution of preclinical Alzheimer's disease: implications for prevention trials.

Authors:  Reisa Sperling; Elizabeth Mormino; Keith Johnson
Journal:  Neuron       Date:  2014-11-05       Impact factor: 17.173

7.  Cortical β-amyloid burden, gray matter, and memory in adults at varying APOE ε4 risk for Alzheimer's disease.

Authors:  Adam P Mecca; Nicole M Barcelos; Shuo Wang; Anna Brück; Nabeel Nabulsi; Beata Planeta-Wilson; Jennifer Nadelmann; Amanda L Benincasa; Jim Ropchan; Yiyun Huang; Joel Gelernter; Peter H Van Ness; Richard E Carson; Christopher H van Dyck
Journal:  Neurobiol Aging       Date:  2017-10-06       Impact factor: 4.673

8.  How technology is reshaping cognitive assessment: Lessons from the Framingham Heart Study.

Authors:  Rhoda Au; Ryan J Piers; Sherral Devine
Journal:  Neuropsychology       Date:  2017-11       Impact factor: 3.295

9.  Beta-amyloid and cognitive decline in late middle age: Findings from the Wisconsin Registry for Alzheimer's Prevention study.

Authors:  Lindsay R Clark; Annie M Racine; Rebecca L Koscik; Ozioma C Okonkwo; Corinne D Engelman; Cynthia M Carlsson; Sanjay Asthana; Barbara B Bendlin; Rick Chappell; Christopher R Nicholas; Howard A Rowley; Jennifer M Oh; Bruce P Hermann; Mark A Sager; Bradley T Christian; Sterling C Johnson
Journal:  Alzheimers Dement       Date:  2016-01-21       Impact factor: 21.566

10.  Cerebral amyloidosis associated with cognitive decline in autosomal dominant Alzheimer disease.

Authors:  Fen Wang; Brian A Gordon; Davis C Ryman; Shengmei Ma; Chengjie Xiong; Jason Hassenstab; Alison Goate; Anne M Fagan; Nigel J Cairns; Daniel S Marcus; Eric McDade; John M Ringman; Neill R Graff-Radford; Bernardino Ghetti; Martin R Farlow; Reisa Sperling; Steve Salloway; Peter R Schofield; Colin L Masters; Ralph N Martins; Martin N Rossor; Mathias Jucker; Adrian Danek; Stefan Förster; Christopher A S Lane; John C Morris; Tammie L S Benzinger; Randall J Bateman
Journal:  Neurology       Date:  2015-08-05       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.